Author: healthadmin

GE Healthcare and New York’s six-hospital nonprofit health system have entered into a 10-year, $500 million strategic partnership to bring advanced imaging, AI and other technologies to the provider’s facilities. The partnership with Catholic Health, which GE Healthcare calls Care Alliance, is one of the medical technology company’s largest partnerships to date and is expected to lead to improved care as well as the expansion of new service lines, both partners said in an announcement Thursday morning. More than 1,300 new technologies will be added to more than 40 hospitals and outpatient facilities, about half of which will be implemented…

Thriveworks, a hybrid mental health provider, is launching a dashboard that gives referring providers real-time visibility into patient progress. When a primary care physician or specialist refers a patient to Thriveworks, they can sign in to a dashboard to view important data such as whether the patient was successfully treated, their clinical progress, and the medications prescribed by Thriveworks clinicians. Although the dashboard itself is not integrated with the electronic health record (EHR), certain data regarding outcomes, medications, and diagnoses is already relayed to the EHR by Thriveworks. Additional functionality will be added to your provider dashboard, including the ability…

The Coalition for Health AI (CHAI) on Thursday launched a national initiative aimed at helping public health agencies across the United States responsibly evaluate, implement, and scale generative artificial intelligence solutions. OpenAI and Anthropic donated 10 enterprise licenses as part of an initiative called PULSE (Public health Use case and Learning Scaling Engine). This license has 2,000 seats available for public health workers. “Public health teams are being asked to do more with less, and AI can help them do that, as long as it is deployed with caution and appropriate guardrails,” Elizabeth Kelly, head of beneficial deployment at Anthropic,…

Recent research published in journals neuron provides evidence that a specific group of adrenaline-producing brain cells acts as a key driver of fear and anxiety behaviors. Activation of these cells causes immediate and long-term anxiety, and decreased activation of these cells reduces stress responses. These findings suggest that targeting these specific neurons may provide a more precise way to treat anxiety disorders in the future. Anxiety disorders affect more than 300 million people worldwide and have a significant impact on their daily lives. Current treatments, including various medications and therapies, can cause side effects such as insomnia, irritability, and cognitive…

HIRI is a major clinical challenge that occurs when the blood supply to the liver is temporarily interrupted and then recovered, as is often seen in liver resection or liver transplantation. Current research indicates that this injury involves oxidative stress, mitochondrial dysfunction, metabolic imbalance, and excessive inflammation. Strategies such as shortening ischemic time, ischemic preconditioning, antioxidants, and mitochondrial protectants have been investigated, but their protective effects remain limited. An important unresolved question is how mitochondrial lipid metabolism, mtDNA-centered oxidative stress, and inflammatory signaling interact to amplify liver damage.The study (DOI: 10.48130/targetome-0026-0011) target tome On March 31, 2026, Xiaojiaoyang Li’s team…

For many cancer survivors, cannabis is part of the way they manage symptoms such as pain, nausea, and anxiety. Medical marijuana is now legal in 47 states, Washington, D.C., and three U.S. territories, and its use continues to grow among both the general population and cancer survivors. However, despite its increasing use, little is known about how survivors and their health care providers view medical cannabis or how comfortable they are discussing it. A new study from VCU Massey Comprehensive Cancer Center surveyed 395 cancer survivors and 62 cancer care providers to better understand these perspectives. Published in Cancer Education…

We all age at different rates, and no one is immune to aging. A study by researchers at Stanford Medicine using mouse and human cells found that the main culprit is that as we age, certain types of immune cells become less able to engulf other types of immune cells. So-called tissue-resident macrophages are thought to be central regulators of age-related organ deterioration. Blocking a single receptor on these cells preserved the youth of multiple organs in mice, including the brain, heart, skeletal and cardiac muscle, liver, spleen, bone marrow, kidney, and colon. This receptor specifically binds to a hormone…

Researchers at the Icahn School of Medicine at Mount Sinai have identified immune cells that form within tumors and act as builders and regulators of powerful immune hubs that play a key role in anti-tumor immunity. This discovery could lead to new strategies to make cancer immunotherapy more effective. The findings were published online on July 16th. science (DOI:10.1126/science.ady1678) revealed that specialized immune cells called dendritic cell type 1 are essential for the construction and maintenance of structures known as tertiary lymphoid structures (TLS). These organized clusters of immune cells act as local command centers, or immune “outposts,” where the…

By analyzing individual cancer cells, researchers at the Free University of Bruxelles (ULB) discovered the transcriptional regulators that govern tumor EMT, identified key master regulators that control metastasis, and uncovered new therapeutic vulnerabilities to halt metastatic dissemination. Metastasis is the process by which cancer cells spread to other organs far from their original site and is responsible for 90% of deaths in cancer patients. To cause metastasis, cancer cells undergo epithelial-to-mesenchymal transition (EMT). This is a cellular process that allows cancer cells to detach from neighboring cells, spread into the blood, and reach distant organs. Rather than a simple on/off…

Lower doses of COVID-19 booster vaccines may provide longer-lasting immunity, reducing costs and improving access to vaccination, according to a new study. The findings could also inform vaccine doses and options during future pandemics. An international research program led by the Murdoch Children’s Research Institute (MCRI) and involving more than 2,000 participants from Australia, Indonesia and Mongolia has provided new evidence to help shape future strategies to prevent the spread of COVID-19. The $17.6 million program, funded by the Coalition for Epidemic Preparedness Innovations (CEPI), evaluated various COVID-19 booster approaches through three randomized clinical trials that followed participants for up…